ProBioGen AG
Andrea Hauptmann has extensive work experience in finance and administration roles. Andrea is currently serving as the CFO at MiGenTra GmbH since October 2021. Prior to this, they held various positions at ProBioGen AG, including CFO from January 2021, VP Finance & Administration from April 2015 to December 2020, and Director Finance & Administration from July 2009 to March 2015. Andrea also worked as a Corporate Controller at ORCO Immobilien GmbH from June 2008 to June 2009 and as a Controllerin/Beteiligungscontrollerin from September 2005 to June 2008.
Andrea Hauptmann attended Technical University (TH) Zittau, where they completed their studies in Economics and obtained a Diploma in 1989. The specific years of their education are not provided in the given information.
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.